Tokyo, Sept. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062823) titled 'A Study to Evaluate the Effectiveness of a Decision Support Program Using a Question Prompt List and Nurse-led Navigation for Patients with Hematological Malignancies (MagiQ Study)' on Sept. 8.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -no one is blinded Control - Active

Primary Sponsor: Institute - Kansai Medical University

Condition: Condition - Adult patients newly diagnosed with diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, or myelodysplastic syndrome who are scheduled to receive first-line treatment Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - To evaluate whether a decision support program combining a Question Prompt List(QPL) with nurse-led navigation improves patients' satisfaction with decision support compared with usual care among patients with hematological malignancies. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - In addition to receiving the common booklet, participants will receive a single session of a decision support program consisting of nurse-led navigation using a Question Prompt List (QPL) for patients with hematological malignancies before the physician consultation. Interventions/Control_2 - Participants will receive usual care, including the common booklet provided to both groups.

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1. Patients who are able to communicate in Japanese. 2. Patients who have received a sufficient explanation of the study, fully understood its content, and provided written informed consent to participate of their own free will. Key exclusion criteria - 1. Patients with a history of chemotherapy or radiotherapy. 2. Patients whom a physician judges to be unable to participate in the study because of a marked decline in physical functioning or severe distress. 3. Patients with a serious psychiatric disorder or dementia. Target Size - 292

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 08 Month 17 Day Date of IRB - 2026 Year 08 Month 17 Day Anticipated trial start date - 2026 Year 09 Month 28 Day Last follow-up date - 2028 Year 09 Month 30 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066184

Disclaimer: Curated by HT Syndication.